CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benoxaprofen
Accession: CHEBI:76114
browse the term
Definition: A monocarboxylic acid that is propionic acid substituted at position 2 by a 2-(4-chlorophenyl)-1,3-benzoxazol-5-yl group. It was used as a non-steroidal anti-inflammatory drug until 1982 when it was withdrawn from the market due to adverse side-effects including liver necrosis, photosensitivity, and carcinogenicity in animals.
Synonyms: exact_synonym: 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
related_synonym: (1)-2-(4-Chlorophenyl)benzoxazole-5-propionic acid; 2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid; 2-(p-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid; DL-benoxaprofen; Formula=C16H12ClNO3; InChI=1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20); InChIKey=MITFXPHMIHQXPI-UHFFFAOYSA-N; Lilly 90459; SMILES=CC(C(O)=O)c1ccc2oc(nc2c1)-c1ccc(Cl)cc1; benoxaprofene; benoxaprofeno; benoxaprofenum
xref: CAS:51234-28-7; DrugBank:DB04812; Drug_Central:311; KEGG:D03080
xref_mesh: MESH:C011677
xref: PMID:19439485; PMID:19773537; PMID:21128314; PMID:22514582; PMID:23250699; PMID:2413686; PMID:2833969; PMID:2947294; PMID:3981515; PMID:6407402; PMID:6526401; PMID:6645654; PMID:6813936; PMID:6993669; PMID:6993670; PMID:6993671; PMID:6993672; PMID:7044799; PMID:7044801; PMID:7084283; PMID:7084287; PMID:7221526; Patent:DE2324443; Patent:US3912748; Patent:US4391814; Patent:US6338855; Patent:WO2008020270; Reaxys:1085080; Wikipedia:Benoxaprofen
G
Alb
albumin
decreases response to substance
ISO
ALB protein results in decreased susceptibility to benoxaprofen
CTD
PMID:6699424
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
decreases activity
EXP
benoxaprofen results in decreased activity of ALOX12 protein
CTD
PMID:3928952
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions decreases activity
ISO EXP
[benoxaprofen results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4; [benoxaprofen results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid
CTD
PMID:2724698 PMID:2849922 PMID:3020588 PMID:3928952
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression decreases activity
EXP ISO
benoxaprofen results in increased expression of CYP1A1 protein benoxaprofen results in decreased activity of CYP1A1 protein
CTD
PMID:2069584 PMID:33814510
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
benoxaprofen results in increased expression of CYP1A2 protein
CTD
PMID:2069584
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
benoxaprofen results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
increases expression
EXP
benoxaprofen results in increased expression of CYP4A1 protein
CTD
PMID:2069584
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
increases expression
EXP
benoxaprofen results in increased expression of EHHADH protein
CTD
PMID:2069584
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Gusb
glucuronidase, beta
increases secretion
ISO
benoxaprofen results in increased secretion of GUSB protein
CTD
PMID:6737371
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
benoxaprofen inhibits the reaction [LHB protein results in increased abundance of Pregnenolone]; benoxaprofen inhibits the reaction [LHB protein results in increased abundance of Testosterone]
CTD
PMID:6430271
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
affects response to substance
ISO
UGT1A3 affects the susceptibility to benoxaprofen
CTD
PMID:17880178
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
affects response to substance
ISO
UGT1A9 affects the susceptibility to benoxaprofen
CTD
PMID:17880178
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
affects response to substance increases glucuronidation
ISO
UGT2B7 affects the susceptibility to benoxaprofen UGT2B7 protein alternative form results in increased glucuronidation of benoxaprofen
CTD
PMID:8423545 PMID:17880178
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all